Skip to content
Start · Insights · How Investors Evaluate Private Companies: The Eight Things Commonly Considered Before Investing

How Investors Evaluate Private Companies: The Eight Things Commonly Considered Before Investing

Enterprise business meeting

A practical look at the eight criteria private market investors use to screen companies before committing capital, from problem validation to exit path.

Every private investment decision sits on top of a screening process most outside observers never see. Long before a term sheet is drafted, an investment team is quietly working through a set of questions that determine whether a company is even worth deeper diligence. The specific criteria vary by firm, but they tend to cluster around three things: the problem being solved, the people solving it, and the path to a realized return.

This article walks through eight evaluation criteria commonly applied when screening a private investment opportunity, in roughly the order most investment teams actually work through them.

1. Does the company solve a real problem or need?

The starting question is whether the product or service addresses a genuine, sufficiently large problem, not just a clever idea. Evidence usually comes from customer adoption, retention, and willingness to pay rather than from the pitch deck itself. A company that has to spend heavily to convince customers something is necessary is in a structurally weaker position than one whose customers are already underserved and actively looking for a solution.

2. What does the exit landscape actually look like?

Before capital is committed, many investors map the plausible exit paths: an IPO, a strategic acquisition, or a secondary sale. They also look at whether comparable companies in the same sector have historically achieved liquidity events, and on what kind of timeline. A brilliant company in a sector where exits are rare or take fifteen years is a different risk proposition than the same company in a sector with an active acquirer base.

3. How experienced is the management team?

Backgrounds, prior track records, and team composition matter heavily at the growth and late stage, since execution risk, not just idea risk, becomes the dominant variable as a company scales — much of what a founder needs to have in place before a company is investable. A founder who built and scaled a team through 50, then 500, then 2,000 employees has already demonstrated something a first-time founder with a great product has not yet had the chance to prove.

4. What is the actual competitive advantage?

This includes proprietary technology, data, network effects, regulatory positioning, or cost structure: anything that makes the company genuinely difficult for a well-funded competitor to replicate quickly. A defensible competitive advantage is what separates a company that compounds advantage over time from one whose lead can be closed within a single funding cycle.

5. What is the customer benefit or value-add?

A clear, demonstrable improvement for the end customer, whether in efficiency, cost, or capability, tends to correlate with durable demand, as opposed to growth driven primarily by promotional spend or subsidized pricing that cannot be sustained indefinitely.

6. How large is the addressable market, and can the business scale?

Market size can influence the range of potential growth opportunities available to a company, scalability determines how efficiently a company can grow into that ceiling without proportionally increasing costs. Investors may view weak unit economics as a meaningful consideration, even where the addressable market is large.

7. How is ESG factored into the assessment?

Environmental, social, and governance considerations are increasingly assessed alongside financial criteria, both as a risk management lens (regulatory exposure, reputational risk, supply chain dependencies) and, for some investors, as a reflection of personal or institutional values. This has become particularly relevant in sectors like defense technology and energy, where ESG framing and underlying risk genuinely intersect.

8. How is the company valued relative to its stage and peers?

Even a high-quality business may not represent an attractive investment opportunity at certain valuation levels. Valuation is benchmarked against comparable transactions, growth rate, and stage-appropriate revenue or user multiples, since paying a premium for quality is reasonable only up to a point.

Key takeaways

  • Screening criteria typically progress from problem validation through team quality, defensibility, market size, ESG exposure, and finally valuation
  • Execution risk becomes more important than idea risk as a company moves into growth and late-stage rounds
  • Competitive positioning is one factor many investors consider when assessing long-term business prospects
  • Market size alone is not sufficient; unit economics and scalability determine whether growth actually compounds value
  • Valuation discipline matters even when every other criterion looks strong

Frequently Asked Questions

No. Weighting typically shifts by sector and stage. A deep-tech company may be assessed more heavily on competitive advantage, while a consumer business may weight customer traction more heavily.

It is generally applied across direct investments, though the depth of diligence varies by structure and investment size.

Possibly, if other factors are sufficiently strong, though a poor outcome on exit landscape or team quality tends to be harder to offset than a weaker score elsewhere.

Public equity research relies heavily on disclosed financials and market pricing. Private screening relies more on direct access, management interviews, and negotiated information that is not publicly available.

Initial screening can take days; full due diligence on a late-stage round more commonly takes several weeks to a few months, depending on deal complexity and access to information.

No. It reflects the core screening criteria; full due diligence typically goes considerably deeper into financial, legal, and operational review before any capital is committed.

Summary

Screening a private investment opportunity is less about identifying a single best deal and more about systematically working through problem validation, team quality, competitive positioning, market scale, ESG factors, and valuation. A consistent framework, applied early and rigorously, is what filters genuinely strong opportunities from compelling pitches before resource-intensive due diligence begins.

This material is provided for informational and educational purposes only and should not be construed as investment advice, an offer to sell, or a solicitation to buy any security. The factors described above represent examples of considerations that may be relevant when evaluating private investment opportunities. Actual investment decisions vary depending on the circumstances, and no screening process can ensure successful investment outcomes or eliminate the risk of loss.
In this publication
Table Of Contents
About the author

Goldbach Capital is the private markets arm of Alpen Partners, your FINMA-licensed Swiss independent asset manager and family office. We give qualified investors curated access to pre-IPO equity, private credit, and alternative investments through direct deals, pooled vehicles, and select third-party manager partnerships.

Contact us

Goldbach Capital AG
Wolleraustrasse 31
CH – 8807 Freienbach
Switzerland